GB0822394D0 - Formulations - Google Patents

Formulations

Info

Publication number
GB0822394D0
GB0822394D0 GBGB0822394.3A GB0822394A GB0822394D0 GB 0822394 D0 GB0822394 D0 GB 0822394D0 GB 0822394 A GB0822394 A GB 0822394A GB 0822394 D0 GB0822394 D0 GB 0822394D0
Authority
GB
United Kingdom
Prior art keywords
formulations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0822394.3A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Syntopix Group PLC
Original Assignee
Syntopix Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syntopix Ltd filed Critical Syntopix Ltd
Priority to GBGB0822394.3A priority Critical patent/GB0822394D0/en
Publication of GB0822394D0 publication Critical patent/GB0822394D0/en
Priority to GB0921378A priority patent/GB2466110B/en
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/4709Non-condensed quinolines and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/60Salicylic acid; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/10Anti-acne agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB0822394.3A 2008-12-09 2008-12-09 Formulations Ceased GB0822394D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB0822394.3A GB0822394D0 (en) 2008-12-09 2008-12-09 Formulations
GB0921378A GB2466110B (en) 2008-12-09 2009-12-07 Antibacterial formulation for use in the treatment of acne

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0822394.3A GB0822394D0 (en) 2008-12-09 2008-12-09 Formulations

Publications (1)

Publication Number Publication Date
GB0822394D0 true GB0822394D0 (en) 2009-01-14

Family

ID=40289694

Family Applications (2)

Application Number Title Priority Date Filing Date
GBGB0822394.3A Ceased GB0822394D0 (en) 2008-12-09 2008-12-09 Formulations
GB0921378A Expired - Fee Related GB2466110B (en) 2008-12-09 2009-12-07 Antibacterial formulation for use in the treatment of acne

Family Applications After (1)

Application Number Title Priority Date Filing Date
GB0921378A Expired - Fee Related GB2466110B (en) 2008-12-09 2009-12-07 Antibacterial formulation for use in the treatment of acne

Country Status (1)

Country Link
GB (2) GB0822394D0 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20150342990A1 (en) * 2014-05-29 2015-12-03 Metabeauty, Inc Methods and compositions for the use of silver to prevent and treat acne

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3147182A (en) * 1961-03-20 1964-09-01 Johnson & Johnson Antiseptic mixture of decamethylene 1, 10-bis-4-aminoquinaldinium salt and cetyl pridinium salt
RO59301A2 (en) * 1972-07-26 1976-01-15
JP2000212090A (en) * 1999-01-18 2000-08-02 Mitsuko Ito Skin-modifying agent
US20080070875A1 (en) * 2006-09-11 2008-03-20 Majewski George P Acne treatment compositions and methods of use
GB0618695D0 (en) * 2006-09-22 2006-11-01 Syntopix Ltd Formulations
GB0710899D0 (en) * 2007-06-07 2007-07-18 Syntopix Ltd Formulations
JP2008110999A (en) * 2008-02-04 2008-05-15 Mandom Corp Antibacterial composition and deodorant agent
GB2456376A (en) * 2008-12-22 2009-07-15 Syntopix Ltd Antibacterial/anti-acne formulations comprising a halogenated salicylanilide in combination with one or more anti-acne agents

Also Published As

Publication number Publication date
GB2466110B (en) 2011-01-05
GB0921378D0 (en) 2010-01-20
GB2466110A (en) 2010-06-16

Similar Documents

Publication Publication Date Title
GB0815435D0 (en) Formulations
GB2459691B (en) Formulations
ZA201106050B (en) Dye-polymers formulations
GB0711656D0 (en) Formulations
GB0716385D0 (en) Formulations
GB0823269D0 (en) Formulations
ZA200908969B (en) Formulations
GB0821789D0 (en) Formulations
GB0711957D0 (en) Formulations
GB0919210D0 (en) Formulations
GB0809979D0 (en) Formulations
HUE054030T2 (en) Improved formulations
EP2307021A4 (en) Formulations
GB0806978D0 (en) Novel formulations
GB0822633D0 (en) Formulation
GB0810232D0 (en) Formulations
ZA201004772B (en) Novel formulation
GB0814376D0 (en) Formulation
GB0705179D0 (en) Formulations
GB0921378D0 (en) Formulations
GB0916030D0 (en) Formulations
GB0822171D0 (en) Temisartan formulations
IL217390A0 (en) Formulations
GB0823486D0 (en) Formulations
GB0916106D0 (en) Formulations

Legal Events

Date Code Title Description
COOA Change in applicant's name or ownership of the application

Owner name: SYNTOPIX GROUP PLC

Free format text: FORMER OWNER: SYNTOPIX LIMITED

AT Applications terminated before publication under section 16(1)